BY THE DAILY EXPOSE ON  

A confidentiality agreement shows potential coronavirus vaccine candidates were transferred from Moderna to the University of North Carolina in 2019, nineteen days prior to the emergence of the alleged Covid-19 causing virus in Wuhan, China.

The confidentially agreement which can be viewed here states that providers ‘Moderna’ alongside the ‘National Institute of Allergy and Infectious Diseases’ (NIAID) agreed to tranfer ‘mRNA coronavirus vaccine candidates’ developed and jointly-owned by NIAID and Moderna to recipients ‘The Universisty of North Carolina at Chapel Hill’ on the 12th December 2019.

Found on page 105 of the agreement

The material transfer agreement was signed the December 12th 2019 by Ralph Baric, PhD, at the University of North Carolina at Chapel Hill, and then signed by Jacqueline Quay, Director of Licensing and Innovation Support at the University of North Carolina on December 16th 2019.

Recipient signatories found on page 107

The agreement was also signed by two representatives of the NIAID, one of whom was Amy F. Petrik PhD, a technology transfer specialist who signed the agreement on December 12th 2019 at 8:05 am. The other signatory was Barney Graham MD PhD, an investigator for the NIAID, however this signature was not dated.

NIAID signatories found on page 107

The final signatories on the agreement were Sunny Himansu, Moderna’s Investigator, and Shaun Ryan, Moderna’s Deputy General Councel. Both signautres were made on December 17th 2019.

Moderna signatories found on page 108

All of these signatures were made prior to any knowledge of the alleged emergence of the novel coronavirus. It wasn’t until December 31st 2019 that the World Health Organisation (WHO) became aware of an alleged cluster of viral pneumonia cases in Wuhan, China. But even at this point they had not determined that an alleged new coronavirus was to blame, instead stating the pneumonia was of “unknown cause”.

It was not until January 9th 2020 that the WHO reported Chinese authorities had determined the outbreak was due to a novel coronavirus which later became known as SARS-CoV-2 with the alleged resultant disease dubbed COVID-19. So why was an mRNA coronavirus vaccine candidate developed by Moderna being transferred to the University of North Carolina on December 12th 2019?

The same Moderna that have had an mRNA coronavirus vaccine authorised for emergency use only in both the United Kingdom and United States to allegedly combat Covid-19.

What did Moderna know that we didn’t? In 2019 there was not any singular coronavirus posing a threat to humanity which would warrant a vaccine, and evidence suggests there hasn’t been a singular coronavirus posing a threat to humanity throughout 2020 and 2021 either.

Considering the fact a faulty PCR test has been used at a high cycle rate, hospitals have been empty in comparison to previous years, statistics show just 0.2% of those allegedly infected have died within 28 days of an alleged positive test result, the majority of those deaths by a mile have been people over the age of 85, and a mass of those deaths were caused by a drug called midazolam, which causes respiratory depression, and respiratory arrest.

Perhaps Moderna and the National Institute of Allergy and Infectious Diseases would like to explain themselves in a court of law? – THE DAILY EXPOSE 

To be continued?
Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

I’m trying to advance the discussion, but apparently most are still stuck at “these are not even vaccines”. Yeah, we knew that the moment we visited a manufacturer’s website, which is among the first reasonable things to do. I hope this will help closing that debate and will ease stepping further down the rabbit hole. Watch how many will find out these things from me rather than from the original source!

mRNA doesn’t alter DNA?

mRNA is just as critical as DNA.

source: Moderna

Without mRNA, your genetic code would never get used by your body. Proteins would never get made. And your body wouldn’t – actually couldn’t – perform its functions. Messenger ribonucleuc acid, or mRNA for short, plays a vital role in human biology, specifically in a process known as protein synthesis. mRNA is a single-stranded molecule that carries genetic code from DNA in a cell’s nucleus to ribosomes, the cell’s protein-making machinery.

Moderna

Our Operating System

Recognizing the broad potential of mRNA science, we set out to create an mRNA technology platform that functions very much like an operating system on a computer. It is designed so that it can plug and play interchangeably with different programs. In our case, the “program” or “app” is our mRNA drug – the unique mRNA sequence that codes for a protein.

We have a dedicated team of several hundred scientists and engineers solely focused on advancing Moderna’s platform technology. They are organized around key disciplines and work in an integrated fashion to advance knowledge surrounding mRNA science and solve for challenges that are unique to mRNA drug development. Some of these disciplines include mRNA biology, chemistry, formulation & delivery, bioinformatics and protein engineering.

Our mRNA Medicines – The ‘Software of Life’

When we have a concept for a new mRNA medicine and begin research, fundamental components are already in place.

Generally, the only thing that changes from one potential mRNA medicine to another is the coding region – the actual genetic code that instructs ribosomes to make protein. Utilizing these instruction sets gives our investigational mRNA medicines a software-like quality. We also have the ability to combine different mRNA sequences encoding for different proteins in a single mRNA investigational medicine.

We are leveraging the flexibility afforded by our platform and the fundamental role mRNA plays in protein synthesis to pursue mRNA medicines for a broad spectrum of diseases.

Within a given modality, the base components are generally identical across development candidates – formulation, 5’ region and 3’ region. Only the coding region varies based on the protein/s the potential medicine is directing cells to produce.

Learn how our Research Engine and Early Development Engine are enabling us to fully maximize the promise of mRNA to meaningfully improve how medicines are discovered, developed and manufactured.

‘Life is just a flow of information. And we’re interfering with it”

Overcoming Key Challenges

Using mRNA to create medicines is a complex undertaking and requires overcoming novel scientific and technical challenges. We need to get the mRNA into the targeted tissue and cells while evading the immune system. If the immune system is triggered, the resultant response may limit protein production and, thus, limit the therapeutic benefit of mRNA medicines. We also need ribosomes to think the mRNA was produced naturally, so they can accurately read the instructions to produce the right protein. And we need to ensure the cells express enough of the protein to have the desired therapeutic effect. 

Our multidisciplinary platform teams work together closely to address these scientific and technical challenges. This intensive cross-functional collaboration has enabled us to advance key aspects of our platform and make significant strides to deliver mRNA medicines for patients.

MODERNA

SOFTWARE OF LIFE™ Research and Design Services

Our mRNA RESEARCH ENGINE™ services enable us to advance new product ideas into development candidates via our drug discovery efforts, and includes infrastructure to enable rapid supply of thousands of preclinical mRNAs for research involving in vitro and in vivo experiments in order to accelerate programs from idea to development candidate designation.

 

mRNA Design Studio™ – Digital Design and Ordering of mRNA for Research

Our mRNA Design Studio enables rapid design of multiple mRNAs.

As our scientists create new mRNA concepts, they can design mRNAs for research and testing, within days, using our proprietary systems. As the Digital Biotech Company™, we utilize the software-like property of mRNA in our proprietary, web-based mRNA Design Studio. Our scientists request mRNAs for a specific protein, and the protein target is automatically converted to an initial optimized mRNA sequence. Using our Sequence Designer module, they can tailor entire mRNAs from the 5’-UTR to the coding region to the 3’-UTR based on our ever-improving proprietary learnings. The mRNA sequence is then further optimized using our proprietary bioinformatics algorithms. Our digital ordering then ensures rapid and accurate transmission of sequences to our modular synthesis robotics.

Our proprietary in-house digital application suite contains a Sequence Designer module to tailor an entire mRNA, with ever-improving rule sets that contain our accumulated learning about mRNA design. Drug Design Studio utilizes cloud-based computational capacity to run various algorithms we have developed to design each mRNA sequence. The utility of cloud-based capacity allows us to provide flexible computational capacity on demand, allowing the Research Engine to power parallel intake and design of multiple mRNA sequences.

Moderna’s Research Engine

Our Research Engine combines proprietary digital drug design tools and a highly automated production facility to enable Moderna and our strategic collaborators to move mRNA medicines swiftly through the research stage, from idea to development candidate nomination.

Scientists can begin by selecting any protein in the human proteome to be further engineered, including antibodies, or they can design novel proteins like traps, fusion proteins, or completely novel scaffolds and sequences. All can be designed to explore previously undruggable pathways.

The Drug Design Studio integrates with Moderna’s automation platforms – directing orders through each phase of mRNA synthesis. Once the order is placed, Moderna’s high-throughput mRNA pre-clinical production facility manages the manufacturing of mRNA constructs and delivers them in just weeks.

MODERNA

Is Humanity even trying to survive?!

PS: Some people wonder why the vids above are available on their website but unlisted on their Youtube.
It’s because they know you won’t look for them on their site, mostly potential partners will.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

We gave up on our profit shares from masks, if you want to help us, please use the donation button!
We think frequent mask use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness.
Get it here!

It’s a bit too late, but you can start freaking out

SHARE THIS MEME
ORDER THE BOOK
Credits for the video mentioned there go to Tim Truth.

Initially I didn’t pay much attention to these reports because first ones were pretty vague and seemed unsubstantiated. They kind of were.
But then they started to become more and more detailed, coherent and very specific. My own research on #biohacking started to intersect more often, to the point where today they almost coincide.

Video by Tim Truth

To better understand where I’m coming from, your journey needs to start here:

Yes, they CAN vaccinate us through nasal test swabs AND target the brain (Biohacking P.1)

and here:

OBAMA, DARPA, GSK AND ROCKEFELLER’S $4.5B B.R.A.I.N. INITIATIVE – BETTER SIT WHEN YOU READ

After you read these, it’s much easier to dive into these new findings:

SOURCE
SOURCE
“cross the blood-brain barrier” as in “ Yes, they CAN vaccinate us through nasal test swabs AND target the brain

Did Yuval Harari say “a second artificial immune system”?

Profusa, Inc. Awarded $7.5M DARPA Grant to Develop Tissue-integrated Biosensors for Continuous Monitoring of Multiple Body Chemistries


NEWS PROVIDED BY Profusa, Inc. 

Jul 12, 2016, 08:30 ET


SOUTH SAN FRANCISCO, Calif., July 12, 2016 /PRNewswire/ — Profusa, Inc., a leading developer of tissue-integrated biosensors, today announced that it was awarded a $7.5 million dollar grant from the Defense Advanced Research Projects Agency (DARPA) and the U.S. Army Research Office (ARO) to develop implantable biosensors for the simultaneous, continuous monitoring of multiple body chemistries. Aimed at providing real-time monitoring of a combat soldier’s health status to improve mission efficiency, the award supports further development of the company’s biosensor technology for real-time detection of the body’s chemical constituents. DARPA and ARO are agencies of the U.S. Department of Defense focused on the developing emerging technologies for use by the military.

SOURCE

“Profusa’s vision is to replace a point-in-time chemistry panel that measures multiple bio­markers, such as oxygen, glucose, lactate, urea, and ions with a biosensor that provides a continuous stream of wireless data,” said Ben Hwang, Ph.D., Profusa’s chairman and chief executive officer. “DARPA’s mission is to make pivotal investments in breakthrough tech­nologies for national security. We are gratified to be awarded this grant to accelerate the development of our novel tissue-integrating sensors for application to soldier health and peak performance.”

Tissue-integrating Biosensors for Multiple Biomarkers
Supported by DARPA, ARO and the National Institutes of Health, Profusa’s technology and unique bioengineering approach overcomes the largest hurdle in long-term use of biosensors in the body: the foreign body response. Placed just under the skin with a specially designed injector, each tiny biosensor is a flexible fiber, 2 mm-to-5 mm long and 200-500 microns in dia­meter. Rather than being isolated from the body, Profusa’s biosensors work fully integrated within the body’s tissue — without any metal device or electronics — overcoming the effects of the foreign body response for more than one year.

Each biosensor is comprised of a bioengineered “smart hydrogel” (similar to contact lens mater­ial) forming a porous, tissue-integrating scaffold that induces capillary and cellular in-growth from surrounding tissue. A unique property of the smart gel is its ability to luminesce upon exposure to light in proportion to the concentration of a chemical such as oxygen, glucose or other biomarker.

“Long-lasting, implantable biosensors that provide continuous measurement of multiple body chemistries will enable monitoring of a soldier’s metabolic and dehydration status, ion panels, blood gases, and other key physiological biomarkers,” said Natalie Wisniewski, Ph.D., the principal investigator leading the grant work and Profusa’s co-founder and chief technology officer. “Our ongoing program with DARPA builds on Profusa’s tissue-integrating sensor that overcomes the foreign body response and serves as a technology platform for the detection of multiple analytes.”

Lumee Oxygen Sensing System™
Profusa’s first medical product, the Lumee Oxygen Sensing System, is a single-biomarker sensor designed to measure oxygen. In contrast to blood oxygen reported by other devices, the system incorporates the only technology that can monitor local tissue oxygen. When applied to the treatment of peripheral artery disease (PAD), it prompts the clinician to provide therapeutic action to ensure tissue oxygen levels persist throughout the treatment and healing process.

Pending CE Mark, the Lumee system is slated to be available in Europe in 2016 for use by vascular surgeons, wound-healing specialists and other licensed healthcare providers who may benefit in monitoring local tissue oxygen. PAD affects 202 million people worldwide, 27 million of whom live in Europe and North America, with an annual economic burden of more than $74 billion in the U.S. alone.

Profusa, Inc.
Profusa, Inc., based in South San Francisco, Calif., is leading the development of novel tissue-integrated sensors that empowers an individual with the ability to monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Overcoming the body’s response to foreign material for long-term use, its technology promises to be the foundational platform of real-time biochemical detection through the development of tiny bioengineered sensors that become one with the body to detect and continuously transmit actionable, medical-grade data for personal and medical use. See http://www.profusa.com for more information.

The research is based upon work supported by DARPA, the Biological Technologies Office (BTO), and ARO grant [W911NF-16-1-0341]. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of DARPA, BTO, the ARO, or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon.

SOURCE Profusa, Inc.

Related Links

http://www.profusa.com

SOURCE
SOURCE
SOURCE

I SAVED THE BEST FOR LAST

SOURCE
and then you wonder why…

So I can’t say with 100% certainty that what DARPA did and what people found are one and the same thing, but this hits close enough, if this is possible, that is possible, and altogether give 200% x reasons to freak out.

I will keep adding resources and details here, but my point is made.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

If you enabled this Covidiocracy in any way, I’m sorry for you! Even if you have a long life ahead of you, you’ll never experience peace of soul and happiness again.
And in no way you’re welcome to rule over or dictate to any living soul.

UPDATE MAY 30, 2022: HERE WE GO AGAIN

BONUS:

DR. REINER FUELLMICH INTERVIEWS WW2 SURVIVOR VERA SHARAV ON COVIDIOCRACY AND THE HOLOCAUST

How Bush’s grandfather helped Hitler’s rise to power

The Guardian, 25 Sep 2004

Rumours of a link between the US first family and the Nazi war machine have circulated for decades. Now the Guardian can reveal how repercussions of events that culminated in action under the Trading with the Enemy Act are still being felt by today’s president

George Bush’s grandfather, the late US senator Prescott Bush, was a director and shareholder of companies that profited from their involvement with the financial backers of Nazi Germany.

The Guardian has obtained confirmation from newly discovered files in the US National Archives that a firm of which Prescott Bush was a director was involved with the financial architects of Nazism.

His business dealings, which continued until his company’s assets were seized in 1942 under the Trading with the Enemy Act, has led more than 60 years later to a civil action for damages being brought in Germany against the Bush family by two former slave labourers at Auschwitz and to a hum of pre-election controversy.

The evidence has also prompted one former US Nazi war crimes prosecutor to argue that the late senator’s action should have been grounds for prosecution for giving aid and comfort to the enemy.

The debate over Prescott Bush’s behaviour has been bubbling under the surface for some time. There has been a steady internet chatter about the “Bush/Nazi” connection, much of it inaccurate and unfair. But the new documents, many of which were only declassified last year, show that even after America had entered the war and when there was already significant information about the Nazis’ plans and policies, he worked for and profited from companies closely involved with the very German businesses that financed Hitler’s rise to power. It has also been suggested that the money he made from these dealings helped to establish the Bush family fortune and set up its political dynasty.

Remarkably, little of Bush’s dealings with Germany has received public scrutiny, partly because of the secret status of the documentation involving him. But now the multibillion dollar legal action for damages by two Holocaust survivors against the Bush family, and the imminent publication of three books on the subject are threatening to make Prescott Bush’s business history an uncomfortable issue for his grandson, George W, as he seeks re-election.

While there is no suggestion that Prescott Bush was sympathetic to the Nazi cause, the documents reveal that the firm he worked for, Brown Brothers Harriman (BBH), acted as a US base for the German industrialist, Fritz Thyssen, who helped finance Hitler in the 1930s before falling out with him at the end of the decade. The Guardian has seen evidence that shows Bush was the director of the New York-based Union Banking Corporation (UBC) that represented Thyssen’s US interests and he continued to work for the bank after America entered the war.

Tantalising

Bush was also on the board of at least one of the companies that formed part of a multinational network of front companies to allow Thyssen to move assets around the world.

Thyssen owned the largest steel and coal company in Germany and grew rich from Hitler’s efforts to re-arm between the two world wars. One of the pillars in Thyssen’s international corporate web, UBC, worked exclusively for, and was owned by, a Thyssen-controlled bank in the Netherlands. More tantalising are Bush’s links to the Consolidated Silesian Steel Company (CSSC), based in mineral rich Silesia on the German-Polish border. During the war, the company made use of Nazi slave labour from the concentration camps, including Auschwitz. The ownership of CSSC changed hands several times in the 1930s, but documents from the US National Archive declassified last year link Bush to CSSC, although it is not clear if he and UBC were still involved in the company when Thyssen’s American assets were seized in 1942.

Three sets of archives spell out Prescott Bush’s involvement. All three are readily available, thanks to the efficient US archive system and a helpful and dedicated staff at both the Library of Congress in Washington and the National Archives at the University of Maryland.

The first set of files, the Harriman papers in the Library of Congress, show that Prescott Bush was a director and shareholder of a number of companies involved with Thyssen.

The second set of papers, which are in the National Archives, are contained in vesting order number 248 which records the seizure of the company assets. What these files show is that on October 20 1942 the alien property custodian seized the assets of the UBC, of which Prescott Bush was a director. Having gone through the books of the bank, further seizures were made against two affiliates, the Holland-American Trading Corporation and the Seamless Steel Equipment Corporation. By November, the Silesian-American Company, another of Prescott Bush’s ventures, had also been seized.

The third set of documents, also at the National Archives, are contained in the files on IG Farben, who was prosecuted for war crimes.

A report issued by the Office of Alien Property Custodian in 1942 stated of the companies that “since 1939, these (steel and mining) properties have been in possession of and have been operated by the German government and have undoubtedly been of considerable assistance to that country’s war effort”.

Prescott Bush, a 6ft 4in charmer with a rich singing voice, was the founder of the Bush political dynasty and was once considered a potential presidential candidate himself. Like his son, George, and grandson, George W, he went to Yale where he was, again like his descendants, a member of the secretive and influential Skull and Bones student society. He was an artillery captain in the first world war and married Dorothy Walker, the daughter of George Herbert Walker, in 1921.

In 1924, his father-in-law, a well-known St Louis investment banker, helped set him up in business in New York with Averill Harriman, the wealthy son of railroad magnate E H Harriman in New York, who had gone into banking.

One of the first jobs Walker gave Bush was to manage UBC. Bush was a founding member of the bank and the incorporation documents, which list him as one of seven directors, show he owned one share in UBC worth $125.

The bank was set up by Harriman and Bush’s father-in-law to provide a US bank for the Thyssens, Germany’s most powerful industrial family.

August Thyssen, the founder of the dynasty had been a major contributor to Germany’s first world war effort and in the 1920s, he and his sons Fritz and Heinrich established a network of overseas banks and companies so their assets and money could be whisked offshore if threatened again.

By the time Fritz Thyssen inherited the business empire in 1926, Germany’s economic recovery was faltering. After hearing Adolf Hitler speak, Thyssen became mesmerised by the young firebrand. He joined the Nazi party in December 1931 and admits backing Hitler in his autobiography, I Paid Hitler, when the National Socialists were still a radical fringe party. He stepped in several times to bail out the struggling party: in 1928 Thyssen had bought the Barlow Palace on Briennerstrasse, in Munich, which Hitler converted into the Brown House, the headquarters of the Nazi party. The money came from another Thyssen overseas institution, the Bank voor Handel en Scheepvarrt in Rotterdam.

By the late 1930s, Brown Brothers Harriman, which claimed to be the world’s largest private investment bank, and UBC had bought and shipped millions of dollars of gold, fuel, steel, coal and US treasury bonds to Germany, both feeding and financing Hitler’s build-up to war.

Between 1931 and 1933 UBC bought more than $8m worth of gold, of which $3m was shipped abroad. According to documents seen by the Guardian, after UBC was set up it transferred $2m to BBH accounts and between 1924 and 1940 the assets of UBC hovered around $3m, dropping to $1m only on a few occasions.

In 1941, Thyssen fled Germany after falling out with Hitler but he was captured in France and detained for the remainder of the war.

There was nothing illegal in doing business with the Thyssens throughout the 1930s and many of America’s best-known business names invested heavily in the German economic recovery. However, everything changed after Germany invaded Poland in 1939. Even then it could be argued that BBH was within its rights continuing business relations with the Thyssens until the end of 1941 as the US was still technically neutral until the attack on Pearl Harbor. The trouble started on July 30 1942 when the New York Herald-Tribune ran an article entitled “Hitler’s Angel Has $3m in US Bank”. UBC’s huge gold purchases had raised suspicions that the bank was in fact a “secret nest egg” hidden in New York for Thyssen and other Nazi bigwigs. The Alien Property Commission (APC) launched an investigation.

There is no dispute over the fact that the US government seized a string of assets controlled by BBH – including UBC and SAC – in the autumn of 1942 under the Trading with the Enemy act. What is in dispute is if Harriman, Walker and Bush did more than own these companies on paper.

Erwin May, a treasury attache and officer for the department of investigation in the APC, was assigned to look into UBC’s business. The first fact to emerge was that Roland Harriman, Prescott Bush and the other directors didn’t actually own their shares in UBC but merely held them on behalf of Bank voor Handel. Strangely, no one seemed to know who owned the Rotterdam-based bank, including UBC’s president.

May wrote in his report of August 16 1941: “Union Banking Corporation, incorporated August 4 1924, is wholly owned by the Bank voor Handel en Scheepvaart N.V of Rotterdam, the Netherlands. My investigation has produced no evidence as to the ownership of the Dutch bank. Mr Cornelis [sic] Lievense, president of UBC, claims no knowledge as to the ownership of the Bank voor Handel but believes it possible that Baron Heinrich Thyssen, brother of Fritz Thyssen, may own a substantial interest.”

May cleared the bank of holding a golden nest egg for the Nazi leaders but went on to describe a network of companies spreading out from UBC across Europe, America and Canada, and how money from voor Handel travelled to these companies through UBC.

By September May had traced the origins of the non-American board members and found that Dutchman HJ Kouwenhoven – who met with Harriman in 1924 to set up UBC – had several other jobs: in addition to being the managing director of voor Handel he was also the director of the August Thyssen bank in Berlin and a director of Fritz Thyssen’s Union Steel Works, the holding company that controlled Thyssen’s steel and coal mine empire in Germany.

Within a few weeks, Homer Jones, the chief of the APC investigation and research division sent a memo to the executive committee of APC recommending the US government vest UBC and its assets. Jones named the directors of the bank in the memo, including Prescott Bush’s name, and wrote: “Said stock is held by the above named individuals, however, solely as nominees for the Bank voor Handel, Rotterdam, Holland, which is owned by one or more of the Thyssen family, nationals of Germany and Hungary. The 4,000 shares hereinbefore set out are therefore beneficially owned and help for the interests of enemy nationals, and are vestible by the APC,” according to the memo from the National Archives seen by the Guardian.

Red-handed

Jones recommended that the assets be liquidated for the benefit of the government, but instead UBC was maintained intact and eventually returned to the American shareholders after the war. Some claim that Bush sold his share in UBC after the war for $1.5m – a huge amount of money at the time – but there is no documentary evidence to support this claim. No further action was ever taken nor was the investigation continued, despite the fact UBC was caught red-handed operating a American shell company for the Thyssen family eight months after America had entered the war and that this was the bank that had partly financed Hitler’s rise to power.

The most tantalising part of the story remains shrouded in mystery: the connection, if any, between Prescott Bush, Thyssen, Consolidated Silesian Steel Company (CSSC) and Auschwitz.

Thyssen’s partner in United Steel Works, which had coal mines and steel plants across the region, was Friedrich Flick, another steel magnate who also owned part of IG Farben, the powerful German chemical company.

Flick’s plants in Poland made heavy use of slave labour from the concentration camps in Poland. According to a New York Times article published in March 18 1934 Flick owned two-thirds of CSSC while “American interests” held the rest.

The US National Archive documents show that BBH’s involvement with CSSC was more than simply holding the shares in the mid-1930s. Bush’s friend and fellow “bonesman” Knight Woolley, another partner at BBH, wrote to Averill Harriman in January 1933 warning of problems with CSSC after the Poles started their drive to nationalise the plant. “The Consolidated Silesian Steel Company situation has become increasingly complicated, and I have accordingly brought in Sullivan and Cromwell, in order to be sure that our interests are protected,” wrote Knight. “After studying the situation Foster Dulles is insisting that their man in Berlin get into the picture and obtain the information which the directors here should have. You will recall that Foster is a director and he is particularly anxious to be certain that there is no liability attaching to the American directors.”

But the ownership of the CSSC between 1939 when the Germans invaded Poland and 1942 when the US government vested UBC and SAC is not clear.

“SAC held coal mines and definitely owned CSSC between 1934 and 1935, but when SAC was vested there was no trace of CSSC. All concrete evidence of its ownership disappears after 1935 and there are only a few traces in 1938 and 1939,” says Eva Schweitzer, the journalist and author whose book, America and the Holocaust, is published next month.

Silesia was quickly made part of the German Reich after the invasion, but while Polish factories were seized by the Nazis, those belonging to the still neutral Americans (and some other nationals) were treated more carefully as Hitler was still hoping to persuade the US to at least sit out the war as a neutral country. Schweitzer says American interests were dealt with on a case-by-case basis. The Nazis bought some out, but not others.

The two Holocaust survivors suing the US government and the Bush family for a total of $40bn in compensation claim both materially benefited from Auschwitz slave labour during the second world war.

Kurt Julius Goldstein, 87, and Peter Gingold, 85, began a class action in America in 2001, but the case was thrown out by Judge Rosemary Collier on the grounds that the government cannot be held liable under the principle of “state sovereignty”.

Jan Lissmann, one of the lawyers for the survivors, said: “President Bush withdrew President Bill Clinton’s signature from the treaty [that founded the court] not only to protect Americans, but also to protect himself and his family.”

Lissmann argues that genocide-related cases are covered by international law, which does hold governments accountable for their actions. He claims the ruling was invalid as no hearing took place.

In their claims, Mr Goldstein and Mr Gingold, honorary chairman of the League of Anti-fascists, suggest the Americans were aware of what was happening at Auschwitz and should have bombed the camp.

The lawyers also filed a motion in The Hague asking for an opinion on whether state sovereignty is a valid reason for refusing to hear their case. A ruling is expected within a month.

The petition to The Hague states: “From April 1944 on, the American Air Force could have destroyed the camp with air raids, as well as the railway bridges and railway lines from Hungary to Auschwitz. The murder of about 400,000 Hungarian Holocaust victims could have been prevented.”

The case is built around a January 22 1944 executive order signed by President Franklin Roosevelt calling on the government to take all measures to rescue the European Jews. The lawyers claim the order was ignored because of pressure brought by a group of big American companies, including BBH, where Prescott Bush was a director.

Lissmann said: “If we have a positive ruling from the court it will cause [president] Bush huge problems and make him personally liable to pay compensation.”

The US government and the Bush family deny all the claims against them.

In addition to Eva Schweitzer’s book, two other books are about to be published that raise the subject of Prescott Bush’s business history. The author of the second book, to be published next year, John Loftus, is a former US attorney who prosecuted Nazi war criminals in the 70s. Now living in St Petersburg, Florida and earning his living as a security commentator for Fox News and ABC radio, Loftus is working on a novel which uses some of the material he has uncovered on Bush. Loftus stressed that what Prescott Bush was involved in was just what many other American and British businessmen were doing at the time.

“You can’t blame Bush for what his grandfather did any more than you can blame Jack Kennedy for what his father did – bought Nazi stocks – but what is important is the cover-up, how it could have gone on so successfully for half a century, and does that have implications for us today?” he said.

“This was the mechanism by which Hitler was funded to come to power, this was the mechanism by which the Third Reich’s defence industry was re-armed, this was the mechanism by which Nazi profits were repatriated back to the American owners, this was the mechanism by which investigations into the financial laundering of the Third Reich were blunted,” said Loftus, who is vice-chairman of the Holocaust Museum in St Petersburg.

“The Union Banking Corporation was a holding company for the Nazis, for Fritz Thyssen,” said Loftus. “At various times, the Bush family has tried to spin it, saying they were owned by a Dutch bank and it wasn’t until the Nazis took over Holland that they realised that now the Nazis controlled the apparent company and that is why the Bush supporters claim when the war was over they got their money back. Both the American treasury investigations and the intelligence investigations in Europe completely bely that, it’s absolute horseshit. They always knew who the ultimate beneficiaries were.”

“There is no one left alive who could be prosecuted but they did get away with it,” said Loftus. “As a former federal prosecutor, I would make a case for Prescott Bush, his father-in-law (George Walker) and Averill Harriman [to be prosecuted] for giving aid and comfort to the enemy. They remained on the boards of these companies knowing that they were of financial benefit to the nation of Germany.”

Loftus said Prescott Bush must have been aware of what was happening in Germany at the time. “My take on him was that he was a not terribly successful in-law who did what Herbert Walker told him to. Walker and Harriman were the two evil geniuses, they didn’t care about the Nazis any more than they cared about their investments with the Bolsheviks.”

What is also at issue is how much money Bush made from his involvement. His supporters suggest that he had one token share. Loftus disputes this, citing sources in “the banking and intelligence communities” and suggesting that the Bush family, through George Herbert Walker and Prescott, got $1.5m out of the involvement. There is, however, no paper trail to this sum.

The third person going into print on the subject is John Buchanan, 54, a Miami-based magazine journalist who started examining the files while working on a screenplay. Last year, Buchanan published his findings in the venerable but small-circulation New Hampshire Gazette under the headline “Documents in National Archives Prove George Bush’s Grandfather Traded With the Nazis – Even After Pearl Harbor”. He expands on this in his book to be published next month – Fixing America: Breaking the Stranglehold of Corporate Rule, Big Media and the Religious Right.

In the article, Buchanan, who has worked mainly in the trade and music press with a spell as a muckraking reporter in Miami, claimed that “the essential facts have appeared on the internet and in relatively obscure books but were dismissed by the media and Bush family as undocumented diatribes”.

Buchanan suffers from hypermania, a form of manic depression, and when he found himself rebuffed in his initial efforts to interest the media, he responded with a series of threats against the journalists and media outlets that had spurned him. The threats, contained in e-mails, suggested that he would expose the journalists as “traitors to the truth”.

Unsurprisingly, he soon had difficulty getting his calls returned. Most seriously, he faced aggravated stalking charges in Miami, in connection with a man with whom he had fallen out over the best way to publicise his findings. The charges were dropped last month.

Biography

Buchanan said he regretted his behaviour had damaged his credibility but his main aim was to secure publicity for the story. Both Loftus and Schweitzer say Buchanan has come up with previously undisclosed documentation.

The Bush family have largely responded with no comment to any reference to Prescott Bush. Brown Brothers Harriman also declined to comment.

The Bush family recently approved a flattering biography of Prescott Bush entitled Duty, Honour, Country by Mickey Herskowitz. The publishers, Rutledge Hill Press, promised the book would “deal honestly with Prescott Bush’s alleged business relationships with Nazi industrialists and other accusations”.

In fact, the allegations are dealt with in less than two pages. The book refers to the Herald-Tribune story by saying that “a person of less established ethics would have panicked … Bush and his partners at Brown Brothers Harriman informed the government regulators that the account, opened in the late 1930s, was ‘an unpaid courtesy for a client’ … Prescott Bush acted quickly and openly on behalf of the firm, served well by a reputation that had never been compromised. He made available all records and all documents. Viewed six decades later in the era of serial corporate scandals and shattered careers, he received what can be viewed as the ultimate clean bill.”

The Prescott Bush story has been condemned by both conservatives and some liberals as having nothing to do with the current president. It has also been suggested that Prescott Bush had little to do with Averill Harriman and that the two men opposed each other politically.

However, documents from the Harriman papers include a flattering wartime profile of Harriman in the New York Journal American and next to it in the files is a letter to the financial editor of that paper from Prescott Bush congratulating the paper for running the profile. He added that Harriman’s “performance and his whole attitude has been a source of inspiration and pride to his partners and his friends”.

The Anti-Defamation League in the US is supportive of Prescott Bush and the Bush family. In a statement last year they said that “rumours about the alleged Nazi ‘ties’ of the late Prescott Bush … have circulated widely through the internet in recent years. These charges are untenable and politically motivated … Prescott Bush was neither a Nazi nor a Nazi sympathiser.”

However, one of the country’s oldest Jewish publications, the Jewish Advocate, has aired the controversy in detail.

More than 60 years after Prescott Bush came briefly under scrutiny at the time of a faraway war, his grandson is facing a different kind of scrutiny but one underpinned by the same perception that, for some people, war can be a profitable business.

DOWNLOAD PDF
COVID, HITLER, BLM, THE GREAT RESET – MANY BRANDS, ONE CARTEL. AUSCHWITZ PERFECTED AND GLOBALIZED

To be continued?
Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

WTH ever happened to “verify from three independent sources”? All we have is a letter salad uploaded on a server by CCP and “isolation in cultures”.

Back to the normal programming for the normally-abled:

These guys:

… said this:

This is a video presentation, if YouTube Takes it down again, please look it up on Odysee, Brighteon or Bitchute

MANAGED TO UPDATE THE VIDEO TOO AS OF JULY 2021

Amazing list of investors for Illumina, btw!

HOLLY MACARONI: CDC confirmed piecing together the code for the virus from scraps and apparently different places use different codes, which better explains some incidents. See from minute 5 here

ADDENDUM 1: MODERNA AND PFIZER CONFIRM

MODERNA: WE CREATED OUR JAB IN 2 DAYS!
PFIZER: LOL N00BS!

Pfizer
Moderna

ADDENDUM 2: FACT-CHECKERS CONFIRM

ADDENDUM 3 (SEPT 1ST 20201): FOUND A GEM! PROF. DAVID RASNICK LITERALLY AND INDEPENDENTALY SAID SAME THING: “THIS VIRUS EXISTS ONLY ON COMPUTERS”. AND GOES ON CONFIRMING ALL MY THESIS AND MORE

Prof. David Rasnick PhD is a reputed researcher, a friend of Kari Mullis’ and one of the first to whistleblow on the AIDS hoax. A bit of a hero to me, which makes it all more exciting.

ADDENDUM 4 (FEB 2022): LOUD AND CLEAR

UPDATE JULY 10, 2021

And yet another loud and clear confirmation that no one notices because…

“A bipartisan pair of lawmakers want information from the National Institutes of Health (NIH) about the deletion of data on the genetic sequence of the SARS-CoV-2 virus that could provide answers as to the virus’s origin.

In a letter sent Friday and shared first with The Hill, Reps. Raja Krishnamoorthi (D-Ill.) and Mark Green (R-Tenn.) ask for answers about the missing genetic sequences, and press NIH Director Francis Collins to ensure there are safeguards in place to protect scientific data.

The letter comes after a scientist last month said he found some of the genetic sequences of the virus that had previously been uploaded to an NIH server in March 2020 were subsequently deleted at the request of the Chinese researchers from Wuhan who initially uploaded them.

Jesse Bloom, a principal researcher at the Fred Hutchinson Cancer Research Center, wrote in a preprint paper that he recovered 13 missing sequences that purportedly show the virus was circulating in the Chinese city of Wuhan before a December outbreak of COVID-19 that was linked to a “wet market” selling live animals.

The NIH said the requestor wanted the data removed from the agency’s Sequence Read Archive and indicated it was being submitted to another database. Submitting investigators hold the rights to their data and can request withdrawal of the data, the agency said.

Top U.S. public health officials and experts are increasingly lending credibility to the need for a deeper investigation into the origins of the coronavirus.

Scientists haven’t discovered definitive proof the virus leaked from a lab. But they also have not found hard evidence that shows the virus started in animals before naturally infecting humans, which is why some now argue an investigation is needed.” – The (S)Hill

ALL THEY EVER TALK ABOUT IS DATA, A STREAM OF CHARACHTERS.
I mean it’s hard to feel sorry for the human race when it’s this dumb, eugenicists are not totally wrong, just not in position to decide who dies, because no one is.

UPDATE #4: JUNE 4, 2021

BREAKING! 2ND BATCH OF FAUCI E-MAILS

UPDATE #1 : WE’VE JUST BEEN CONFIRMED BY THE UNFORTUNATE AMATEUR PROPAGANDISTS DISGUISED AS FRANCE PRESSE FACT-CHECKERS

SOURCE

ALL THEY HAVE IS A “POST IT” FROM CHINA!

Ah, and a “Nature publication”, I loled. o_O
What kind of people use “there is no question” as scientific argument/evidence? Pseudo-scientists, snake-oil salesmen and con artists of all kinds.

The sub-zeroes from the CBS-affiliate WUSA9 try to lend a helping hand to their owners, but they double down for us:

They link, as evidence, to this NIH page which ONLY MENTIONS GENBANK, which is the same fridge on which China stuck that “post it” note.
THAT IS ALL THEY HAVE.

WTH ever happened to “verify from three independent sources”?
It used to be Rule #0 in journalism, back when I studied it in college.

Here are a bit over three sources to support something:

SOURCE

FOIs reveal that health/science institutions around the world have no record of SARS-COV-2 isolation/purification, anywhere, ever

SOURCE

“Would a sane person mix a patient sample (containing various sources of genetic material and never proven to contain any particular virus) with transfected monkey kidney cells, fetal bovine serum and toxic drugs, then claim that the resulting concoction is “SARS-COV-2 isolate” and ship it off internationally for use in critical research (including vaccine and test development)?

Because that’s the sort of fraudulent monkey business that’s being passed off as “virus isolation” by research teams around the world.

Just 1 of many examples is shown below – this is from a study cited by the Australian Department of Health as a paper “which led to the isolation of SARS-CoV-2 in culture“. (Can you spot the oxymoron in that quote?)” – Fluoride Free Peel

If you are new to the topic of “virus isolation/purification”, I strongly recommend that you begin by reading the Statement On Virus Isolation by Dr. Andrew Kaufman, Dr. Thomas Cowan and
Sally Fallon Morell, MAhttps://andrewkaufmanmd.com/sovi/
or watch this 5 minute video from Dr. Cowan.

Here are 5 compilation pdfs containing FOI responses from 79 institutions in 22 countries/jurisdictions, re the isolation/purification/existence of “SARS-COV-2”, as well as emails from authors of studies that claimed to have “isolated the virus” and an email from the Head of the Consultant Laboratory for Diagnostic Electron Microscopy of Infectious Pathogens at Germany’s Robert Koch Institut, last updated July 13, 2021 (note: many of these responses were obtained by FOI-submitters other than Michael S. and myself, as indicated further down this page):
Part 1: https://www.fluoridefreepeel.ca/wp-content/uploads/2021/02/FOI-replies-SARS-COV-2-isolation-existence-causation-47-institutions-Feb-12-2021-chrono-part-1.pdf
Part 2: https://www.fluoridefreepeel.ca/wp-content/uploads/2021/02/FOI-replies-SARS-COV-2-isolation-existence-causation-47-institutions-Feb-12-2021-chrono-part-2.pdf
Part 3: https://www.fluoridefreepeel.ca/wp-content/uploads/2021/04/FOI-replies-SARS-COV-2-isolation-purification-existence-part-3-April-3.pdf
Part 4: https://www.fluoridefreepeel.ca/wp-content/uploads/2021/06/FOI-replies-re-SARS-COV-2-purification-existence-June-3-2021-part-4.pdf
Part 5: https://www.fluoridefreepeel.ca/wp-content/uploads/2021/07/FOI-replies-re-SARS-COV-2-purification-existence-July-13-2021-part-5.pdf

UPDATE2:
I discovered this when the video was already up…

Source

“Most of our readers are interested in consumer DNA testing for genealogy and ancestry research. Illumina played a massive role in making these services affordable. All the big DNA testing companies use Illumina’s chip technology.
But some companies are even more closely intertwined with Illumina. I mention briefly in an article on who owns 23andMe that the chip company was an investor in the 2015 funding found of its customer.”

https://www.dataminingdna.com/

“If you’ve ever used 23andMeAncestry.com, or any other genetics-testing service, chances are that your genes were sequenced on machines made by the $25 billion biotech behemoth. Now the undisputed leader in the emerging field of DNA sequencing in the U.S., Illumina has outstripped its rivals by selling its sequencing hardware to medical researchers around the world.”

https://www.fastcompany.com/

As we’ve shown in previous reports, 23andMe is owned by Richard Branson and a former wife and current partner of Google’s founder Sergey Brin. She also happens to be the sister of YouTube CEO.

“23andMe is owned by a sizeable number of large investors spearheaded by Anne Wojcicki (YouTube CEO sister and former Google owner wife – S.m) and Richard Branson. The list of investors with recent ownership stakes in the company includes Altimeter Capital, Fidelity, Casdin Capital, and Foresite Capital.
Since the company was founded in 2006, it has been involved in multiple funding rounds. There were at least 60 investors in 2020 before the merger, including GlaxoSmithKline and Sequoia Capital. Early investors include Alphabet (Google’s parent company) and WuXi Healthcare Ventures (a Chinese company).
When 23andMe merged with Richard Branson’s acquisition company, the existing stakeholders retained ownership of 81% of the merged company.”

dataminingdna.com

According to Wikipedia:

“In 2005, co-founder and former Chief Scientific Officer Anthony Czarnik sued Illumina; see Czarnik v. Illumina Inc.

In 2010, Cornell University and Life Technologies filed a lawsuit against Illumina, alleging that its microarray products infringed on eight patents held by the university and exclusively licensed to the start-up. The case was settled in April 2017 without any finding of fault. In September 2017 both parties asked to have the settlement reviewed, with Cornell accusing both Illumina and Life Technologies of misrepresentation and fraud.[44]

In February 2020, Illumina filed a patent infringement suit against BGI relating to its “CoolMPS” sequencing products.[48] In return BGI has filed patent infringement lawsuits for violation of federal antitrust and California unfair competition laws, claiming use of “fraudulent behavior” to obtain or enforce sequencing patents that it has asserted against BGI, preventing the firm from entering the US market.[49]

“BGI” as in…

BILL GATES’ & BIG TECH’S CHINESE DARLINGS: WORLD’S TOP DNA HARVESTERS, CLONERS, UIGHUR PERSECUTERS (BIOHACKING P.4)

Ah, also…

source

UPDATE 3:

Sharryl Atkinson investigates the source of the virus, finds out no one in US got samples in their lab, moves on trying to find the source of a virus that no one can provide samples / isolation / purification.

UPDATE 4 (hopefully final)

I think we’re done here.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

I survived many tough times focusing on the humor in them. And I find this highly amusing. But even more disturbing, when I look around and I see most people don’t flinch hearing such a claim.

Source

As for insurances and vaccines, the topic of that Forbes article… oh boy, oh boy… Check this out! And then THIS!

Follow up:

To be continued?
Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

“In the early nineties, pioneering steps were taken in the use of mRNA as a therapeutic tool for vaccination. In the following decades, an improved understanding of the mRNA pharmacology, together with novel insights in immunology have positioned mRNA-based technologies as next-generation vaccines.”

Three decades of messenger RNA vaccine development

Like teenagers the world over, Nobel Prize-winning scientist Ralph Steinman had absolutely no idea what he wanted to do when he grew up.

In a 2009 essay, the Canadian-born immunologist and cell biologist described his early school career as unfocused, only landing on an interest in biology and medicine while taking “almost every other course” at McGill University in Montreal while on scholarship as an undergraduate.

This latent interest eventually led him to Harvard Medical School, where he earned his M.D. (also on scholarship), and an internship and residency at Massachusetts General Hospital. In 1970, the young Steinman joined the Laboratory of Cellular Physiology and Immunology at Rockefeller University in New York City as a postdoctoral fellow under cell biologist and immunologist Zanvil A. Cohn. Steinman wanted to know what triggers the body’s immune system to kick into gear to initiate a response, a question few scientists at the time were asking.

Just three years later, while working with cells from the spleens of mice, Steinman and Cohn made the discovery that would shape Steinman’s future: the identification and role of a particular type of white blood cell that sets into motion and controls the body’s immune system. They termed these cells dendritic cells, after the branching, tree-like shape the cells can form.

By identifying this chief component that initiates and regulates an immune response, Steinman had discovered why, when, and how the body’s immune system reacts the way that it does, especially in the face of foreign pathogens. He’d discovered what amounted to the boss cell that kicks off immune reactions and tells other cells what to do and what not to do. Dendritic cells also play a role in autoimmune diseases, inflammation, allergies, and transplant rejections.

This discovery would revolutionize immunotherapy and eventually launch the new field of dendritic cell biology. But at the time, Steinman’s discovery was generally disregarded. Dendritic cells were considered little more than an obscure anomaly by much of the scientific community. To top it off, the cells were difficult to isolate, and low in frequency and abundance to boot. It would take more than 20 years and Steinman’s development of a new method to generate large numbers of dendritic cells for experimental use for the scientific community to finally verify and accept his theories.

His chances for surviving another year were estimated at less than five percent.

Steinman was especially interested in clinical applications for dendritic cells, dedicating much of his career toward the development of new medical therapies and treatments based on his research. His discovery led to the first therapeutic cancer vaccine in 1973, a dendritic cell-based immunotherapy for the treatment of prostate cancer. Other potential immunotherapies that have resulted include cancer and transplantation treatments and vaccines for HIV, malaria, tuberculosis, and the Epstein-Barr virus, some of which have reached clinical trials.

Steinman’s desire to see his research put into practical medical application cannot be overstated. Despite his gentle, almost grandfatherly way of speaking, he often expressed frustration at the slow speed at which experimental therapies escaped the confines of the lab and its theoretical animal and data models to reach actual patients. This impatience took on a new sense of urgency in 2007 when Steinman was diagnosed with Stage 4 (advanced) pancreatic cancer. By the time of his diagnosis, the cancer had already advanced beyond the pancreas and spread to Steinman’s lymph nodes. His chances for surviving another year were estimated at less than five percent.

So, Steinman went to work. In response to his illness, he designed and coordinated a single-case medical study with himself as the sole subject.

In addition to undergoing conventional surgery and chemotherapy, Steinman reached out to the international network of researchers in industry and academia he’d built over his decades-long career. Banding together for this common cause, he and his colleagues developed a variety of personalized cancer treatments, many based on his design and research, including vaccines developed from Steinman’s own tumor cells.

“With ten million persons afflicted each year, no one is entirely immune to cancer and its devastating effects on individuals and families. But recent advances in the development of cancer vaccines—either as therapeutic agents or as preventative measures—are hopeful indicators of progress in this field. This volume comprises invited chapters from world-renowned researchers and clinicians that shed light on recent steps forward in immunotherapeutic and preventive approaches for future cancer vaccines.” – Blackwell Publishing

A close-up look at a dendritic cell, the boss cell that kicks off immune reactions and tells other cells what to do and what not to do.

Despite his general impatience with the speed of the traditional scientific process, Steinman insisted on conducting his personal trial according to established protocols, filing mounds of paperwork with official channels and seeking appropriate permissions for untested therapies just like any other trial. Although his personalized experiment was not controlled, he wanted it well-organized and well-documented so his treatment attempts might not only find a cure for himself but also gather knowledge that could be used to benefit others.

This adherence to protocol, however, became a source of frustration for some of Steinman’s colleagues. Steinman, for example, refused combined therapies that failed to get regulatory approval, even though he and many of his colleagues felt the combined approach had a higher likelihood of success. He also initially refused to undergo multiple treatments at once because doing so would confuse the data being collected. With time of the essence, colleagues had to argue with Steinman to get him to prioritize the possibility of his health and longevity over proper protocol and clean experimental results. All told, Steinman underwent as many as eight experimental therapies, in addition to surgery and chemotherapy, to combat his disease.

Four and a half years after his cancer diagnosis, he died just three days before the Nobel Prize announcement

During his long career, he received numerous awards and honors, including the prestigious Lasker Award (sometimes referred to as the American Nobel) in 2007. While in the midst of his illness and self-experimentation, he was also nominated for the 2011 Nobel Prize in Physiology or Medicine for his discovery of the dendritic cell and subsequent contributions to immunology research and medicine.

Steinman joked often about surviving long enough to witness the awards announcement, and as late as a week before, the possibility seemed likely. But on September 30, 2011, four and a half years after his cancer diagnosis, he died just three days before the Nobel Prize announcement. He was 68 years old.

Nobel Prize rules generally prohibit the awarding of a prize posthumously, but given the unusual circumstances and unfortunate timing of events, the Nobel Committee ruled to allow the honor to stand. Steinman shares the prize with American immunologist Bruce A. Beutler and French biologist Jules A. Hoffman, also for their work in the area of immunity research.

Although no one can be sure of the efficacy of the dendritic cell-based immunotherapies Steinman underwent or which one(s) might have helped, the Nobel Laureate lived more than four times longer than expected. His decades of work have contributed to clinical therapies for cancer and infectious diseases that will benefit patients for generations to come. And despite those early years of unfocused study, even his self-experimentation laid the groundwork for future treatments, including an immunotherapy against pancreatic cancer based on data gathered during Steinman’s final experiment. – Folks Magazine

Ralph M. Steinman’s research while affiliated with The Rockefeller University and other places

Ralph Steinman died days before it was announced that he was to share the Nobel Prize for Medicine. His work had been part of an unorthodox experiment to save his life, wrote Politico journalist Brett Norman, quoted by BBC, 2011.

When Ralph Steinman learned he had pancreatic cancer, the dogged immunologist put his life’s work to the test.

He launched a life-and-death experiment in the most personal of personalised medicine.

By unlucky coincidence, he had been diagnosed with a disease that might benefit from the therapies he had spent his life researching.

Usually, medical research proceeds at a glacial, thorough pace: cell studies lead to studies in small animals which lead to studies in larger animals, which eventually lead to small, highly-selective clinical trials in humans. But Steinman didn’t have that kind of time.

He did, however, have access to world class facilities, cutting-edge technology, and some of the world’s most brilliant medical minds, thanks to his position as a researcher at Rockefeller University.

So Steinman decided to make his own body the ultimate experiment.

He had removed a piece of the tumour that would eventually kill him. He then trained his immune cells to track down any hint of the tumour that might have escaped the surgery, like putting hounds on a scent.

On Friday, four-and-a-half years after he was diagnosed with a disease that kills the vast majority of its victims in less than one, that experiment came to an end.

Steinman died at the end of a week in which he continued his work in the lab. It was a testament to the undying optimism of the scientific enterprise, to the unrelenting man, and to the limits of both.

An open secret

I joined Rockefeller as a science writer to chronicle the work of its researchers – Steinman included – about halfway through one of his experiments on himself.

His experiment was an open secret on campus, registered with the hospital and aided by a long-time friend and staff physician. The sense of hope was palpable, bound up in respect for the man but also something broader.

Could the painstakingly incremental research that seemed to have so much potential on lab animals this once grant a reprieve from certain death?

Of course everyone was rooting for him, and I had a special interest. Toward the end of 1999, my father had a stomach complaint. Over a few months, the initial diagnosis of an ulcer morphed into a death sentence: inoperable, metastatic cancer of the pancreas.

Pancreatic cancer is often known as the “silent killer” because it usually doesn’t produce truly scary symptoms until it has spread beyond repair. After chemotherapy, my dad bounced back for a few months, but the cancer inevitably did, too. He died at home in the early fall of 2000.

Could Steinman beat it?

I hoped so. The work had promise.

“In the last few years of his life, Dr. Ralph Steinman made himself into an extraordinary human lab experiment, testing a series of unproven therapies – including some he helped to create – as he waged a very personal battle with pancreatic cancer.”

– Reuters

‘Skeptical’ science

In 1973, along with his mentor, Zanvil Cohn, Steinman published the discovery of a new class of cell in the immune system – the dendritic cell. Like many new discoveries, his faced a deeply sceptical reception.

The experiments couldn’t be immediately reproduced, but Steinman was convinced of his discovery. He fought for a decade before immunologists began to broadly recognise the central importance of those cells to their field.

In the past 20 years, the study of dendritic cells has spread to hundreds of labs all over the world. Researchers are exploring how they might be harnessed to fight cancer, HIV and transplant rejection, among other major medical problems.

Dendritic cells are the “sentinel cells” of the mammalian immune system. Named after the Greek word for tree, they develop distinctive probing branches when activated, sweeping their environment in search of unwelcome things – like bacteria, viruses, tumours.

When dendritic cells encounter something they don’t like, they take a physical marker of the invader, called an antigen, and present it to B and T cells, the defenders of the body’ s immune system. Those cells then adapt weapons to identify and destroy the interlopers.

Steinman bet that if he could train his dendritic cells to recognise and tag his cancer, they would be able to convince the T and B cells to do the rest.

Dream deferred

There was no good reason to expect that Steinman could fashion a cure for one of the world’s most vicious cancers in time to save his own life. But it was easy to think it was at least possible. The made-for-Hollywood story of the renegade scientist who fights the establishment to prove his discovery, and then uses it to cure himself, was powerful enough to compel hope.

Unfortunately, the dendritic cell-based treatments didn’t work – at least not well enough.

Training Steinman’s dendritic cells to the tumour did generate a “vigorous immune response to mesothelin, a tumour specific antigen,” said Dr. Sarah Schlesigner, a longtime colleague of Steinman’s who ran the trial.

In other words, while there were significant side effects, the therapy seemed to enable him to work much longer than he otherwise would have. Month after month, he remained at the University, continuing his work.

He survived much longer than expected, and continued his research until the end.

Over time, it wasn’t enough.

At least, not enough to save him.

But the research he pioneered continues – and the scientists who continue his work have an extraordinary example to follow. – BBC, 2011

Also read: RNA Used to Alter DNA, Brain Functions and Behavior (Biohacking p.2)

To be continued?
Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

“Imagine a biological computer that operates inside a living cell”
– Dr. Andrew Phillips, head of bio-computation at Microsoft Research.

“The problem we’re trying to solve is really trying to have a more sophisticated diagnosis that can happen automatically inside cells… In this project, we’re trying to use DNA as a programmable material” according to Dr. Neil Dalchau, a scientist at Microsoft Research.

To me, the most striking part in this video is the confirmation that they are after the three-stranded DNA technology Anthony Patch brought up in that sensational 2014 interview, which also earned us a ban from Youtube.

“[Microsoft] are essentially trying to sense, analyze and control molecular information

Georg Seelig, Associate Professor at the Gates-funded University of Washington.

Moderna described mRNA as “an information molecule” and even trademarked the name “mRNA OS” – meaning ‘operating system’, according to bigtechtopia.com
We have Moderna’s head honcho “on tape” describing the mRNA vaccine as “information therapy”:

“Molecular devices made of nucleic acids show great potential for applications ranging from bio-sensing to intelligent nanomedicine. They allow computation to be performed at the molecular scale, while also interfacing directly with the molecular components of living systems. They form structures that are stable inside cells, and their interactions can be precisely controlled by modifying their nucleotide sequences. However, designing correct and robust nucleic acid devices is a major challenge, due to high system complexity and the potential for unwanted interference between molecules in the system. To help address these challenges we have developed the DNA Strand Displacement (DSD) tool, a programming language for designing and simulating computational devices made of DNA. The language uses DNA strand displacement as the main computational mechanism, which allows devices to be designed solely in terms of nucleic acids. DSD is a first step towards the development of design and analysis tools for DNA strand displacement, and complements the emergence of novel implementation strategies for DNA computing.”

Microsoft Research

UPDATE OCT. 29 2021: 3RD DNA STRAND AND COVID INJECTIONS:

Is this 3rd strand anything like…

To be continued?
Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

Not a word from me, learn from experts and manufacturers. And Bill Gates.

IF YOUTUBE TAKES DOWN THE VIDEO, THERE ARE ALTERNATIVE UPLOADS ON LBRY AND BRIGHTEON

Dr. David Martin quoted from a Weston A. Price podcast

Obviously, I’m never recommending anything from Pharmafia ever, I’m just highlighting their BS.

Source: BBC
Source: BBC

Also this:
WHY DID MODERNA UNLIST THIS VIDEO PRESENTATION OF THEIR COVID-19 “VACCINE”?! EVERYONE NEEDS TO WATCH IT

UPDATE:

I unearthed a 2017 Ted Talk featuring the current Moderna boss Tal Zaks, where he describes the mRNA technology that was first meant to treat cancer, he call it “information therapy”, see for yourselves:

Ah, and also this:

UPDATE 2:

DR. TENPENNY EXCELLENTLY SUMS UP THE CASE AGAINST mRNA TECHNOLOGY, SOLIDIFYING EVERYTHING WE’VE EXPOSED:

WE’VE JUST GOT A BAN FROM YOUTUBE FOR TRYING TO MIRROR THIS VIDEO ON OUR CHANNEL, BUT THAT’S ANOTHER STORY. SO FAR IT HOLDS ON THE ORIGINAL CHANNEL, IF THEY TAKE IT DOWN, IT’S ALREADY BACKED ON OUR ODYSEE CHANNEL, SEE THE LINKS PAGE 😉

UPDATE: ANOTHER OPEN ADMISSION: APRIL 2021

To be continued?
Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them